Type
Internal restructuring
Country
Netherlands
Region
West-Nederland; Noord-Holland; Groot-Amsterdam
Location of affected unit(s)
Amsterdam
Sector
Professional Services
Professional, Scientific And Technical Activities
Other Professional, Scientific And Technical Activities
74 - Other Professional, Scientific And Technical Activities

114 jobs
Number of planned job losses
Job loss
Announcement Date
5 October 2023
Employment effect (start)
5 October 2023
Foreseen end date
31 December 2023

Description

UniQure, a biotechnology company working in the field of genomic medicine located in Amsterdam, North-Holland, has announced an internal restructuring plan. This will lead to a reduction of 114 jobs, roughly 20% of all positions.

The company is undergoing restructuring because it has ceased half of its research programmes, as a result of poor results from their most important projects. UniQure expects to save $180 million over the next three years with the cut in programmes and the implementation of the restructuring plan.


Sources

  • 5 October 2023: Het Financieele Dagblad (fd.nl)

Citation

Eurofound (2023), UniQure, Internal restructuring in Netherlands, factsheet number 200367, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/200367.